Evidence map›Paper›PMID 38306404›Full record

ArticlePLoS computational biology2024

Covering Hierarchical Dirichlet Mixture Models on binary data to enhance genomic stratifications in onco-hematology.

Daniele Dall'Olio, Eric Sträng, Amin T Turki, Jesse M Tettero, Martje Barbus, Renate Schulze-Rath, Javier Martinez Elicegui, Tommaso Matteuzzi, Alessandra Merlotti, Luciana Carota and 7 more

Abstract read
In one paragraph

Article in PLoS computational biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Daniele Dall'OlioIRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italia.ORCID 0000-0003-0196-6870
Eric SträngDepartment of Hematology, Oncology and Cancer Immunology, Campus Virchow, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Amin T TurkiDepartment of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany.
Jesse M TetteroDepartment of Hematology, Amsterdam UMC location Vrije Universiteit, Amsterdam, the Netherlands.
Martje BarbusAbbVie Deutschland GmbH & Co KG, Wiesbaden, Germany.
Renate Schulze-RathBayer AG, Berlin, Germany.ORCID 0000-0003-4589-7213
Javier Martinez EliceguiMolecular Genetics in Oncohematology, Institute of Biomedical Research of Salamanca, Salamanca, Spain.
Tommaso MatteuzziDepartment of Physics and Astronomy, University of Florence, Sesto Fiorentino, Italy.
Alessandra MerlottiIRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italia.ORCID 0000-0002-3648-2828
Luciana CarotaDepartment of Medical and Surgical Sciences-DIMEC, University of Bologna, Bologna, Italy.
Claudia SalaDepartment of Medical and Surgical Sciences-DIMEC, University of Bologna, Bologna, Italy.ORCID 0000-0002-4889-1047
Matteo G Della PortaComprehensive Cancer Center, IRCCS Humanitas Clinical and Research Center and Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Enrico GiampieriDepartment of Medical and Surgical Sciences-DIMEC, University of Bologna, Bologna, Italy.
Jesús María Hernández-RivasMolecular Genetics in Oncohematology, Institute of Biomedical Research of Salamanca, Salamanca, Spain.
Lars BullingerDepartment of Hematology, Oncology and Cancer Immunology, Campus Virchow, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Gastone CastellaniDepartment of Medical and Surgical Sciences-DIMEC, University of Bologna, Bologna, Italy.
with the HARMONY Healthcare Alliance Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Onco-hematological studies are increasingly adopting statistical mixture models to support the advancement of the genomically-driven classification systems for blood cancer. Targeting enhanced patients stratification based on the sole role of molecular biology attracted much interest and contributes to bring personalized medicine closer to reality. In onco-hematology, Hierarchical Dirichlet Mixture Models (HDMM) have become one of the preferred method to cluster the genomics data, that include the presence or absence of gene mutations and cytogenetics anomalies, into components. This work unfolds the standard workflow used in onco-hematology to improve patient stratification and proposes alternative approaches to characterize the components and to assign patient to them, as they are crucial tasks usually supported by a priori clinical knowledge. We propose (a) to compute the parameters of the multinomial components of the HDMM or (b) to estimate the parameters of the HDMM components as if they were Multivariate Fisher's Non-Central Hypergeometric (MFNCH) distributions. Then, our approach to perform patients assignments to the HDMM components is designed to essentially determine for each patient its most likely component. We show on simulated data that the patients assignment using the MFNCH-based approach can be superior, if not comparable, to using the multinomial-based approach. Lastly, we illustrate on real Acute Myeloid Leukemia data how the utilization of MFNCH-based approach emerges as a good trade-off between the rigorous multinomial-based characterization of the HDMM components and the common refinement of them based on a priori clinical knowledge.

Indexed as

HematologyLeukemia, Myeloid, AcuteChromosome AberrationsGenomicsHumans

Identifiers

PMID38306404
PMCPMC10880984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.